jc
jc

News Center

Check category
/
/
/
J-Valve technology is officially applied to clinical heart valve implantation surgery into the "minute level"

J-Valve technology is officially applied to clinical heart valve implantation surgery into the "minute level"

  • Categories:News Channel
  • Author:
  • Origin:
  • Time of issue:2017-06-09 14:25
  • Views:

(Summary description)

J-Valve technology is officially applied to clinical heart valve implantation surgery into the "minute level"

(Summary description)

  • Categories:News Channel
  • Author:
  • Origin:
  • Time of issue:2017-06-09 14:25
  • Views:
Information

  On June 8, 2017, Suzhou Jecheng Medical Technology Company announced in Beijing that after rigorous clinical trial procedures, the State Food and Drug Administration approved, "for patients with aortic stenosis, aortic valve insufficiency patients , Or the two cases coexist in patients with "J-Valve involved in artificial biological heart valve" was officially applied to clinical treatment. This is China's first original and has a leading international intellectual property involved in heart valves, is currently the world's only effective minimally invasive treatment of aortic valve insufficiency or stenosis of the solution.

 

  J-Valve involved in artificial biological heart valve technology inventor and patent owner Dr. Zhang said that the current global and traditional valve treatment is through the traditional replacement of heart valve surgery, namely: thoracotomy, cut the heart, Cardiopulmonary bypass, cardiac arrest, suture the valve. Need to neck below the chest out of 30 cm long incision, with the doctor's technology to manually replace the valve, the general operation time up to 3 to 4 hours, the patient needs to endure great pain and blood loss. "Valve is the heart of a door, only the door can be smooth opening and closing, smooth, the heart can be healthy and effective blood supply, once the valve stenosis or can not be closed, the heart will be lack of power failure.

 

X

 

  "J-Valve involved in artificial biological heart valve" system is different from the traditional thoracotomy treatment of heart valve disease of a minimally invasive surgical technique, with no surgery, time is short, low cost, simple operation process, technical requirements are not high, Implant the system's own positioning device to complete the valve replacement surgery, thereby reducing the risk of surgery, so that patients receive timely treatment and other advantages.


  "J-Valve involved in artificial biological heart valve" invention, to solve the heart valve disease this world-class problem, is the world's most advanced valve disease treatment technology. The use of "J-Valve intervention in artificial heart valve" technique for aortic valve replacement, time-consuming only 7-10 minutes, the fastest to reach 2 minutes, and clinical trials are high-risk elderly patients, the average age of 74 years of age , The highest age of 87 years of age ... ... in the past, this age to accept heart valve surgery, in the world of medical profession is very rare things.


  So far, the United States has two minimally invasive heart valve implant system listed, but no implantation after a comprehensive positioning device, greatly affected the success rate of surgery, and "J-Valve intervention in artificial heart valve" is the only one in the world Intelligent three-dimensional positioning of the heart valve system.


  Zhang is the first generation of China's new generation of science from the heart of the surgeon, 28-year-old became the Beijing People's Hospital attending physician. In 1991, Zhang went to Canada, under the tutelage of Professor Columbia professor of Columbia heart painstaking research, has won more than 10 world patents. "J-Valve involved in artificial biological heart valve" technology by the United States and Canada, medical research institutions of all ages, they have to Zhang Lei throwing olive branch, hoping Zhang transferred the technology, but Zhang very "national thousands of people plan" special Invited experts to return to the identity of Suzhou Wujiang Industrial Park, so that valve replacement technology research results "ground to root" and become China's first successful development of Western developed countries, high-end medical technology.


  As of May 2017, "J-Valve involved in artificial heart valve" successively in Sichuan University, West China Hospital, Chinese Academy of Medical Sciences Fu Wai Cardiovascular Hospital, Shanghai Fudan University Zhongshan Hospital, one after another completed the number of clinical trials. Clinical study data show that J-Valve interventional valve after 12 months of clinical observation, not only significant effect, and the indicators, especially all-cause mortality, permanent pacemaker implantation rates are far below the global average The Excellent clinical trial performance by the industry's internationally renowned magazine "American Journal of Cardiology" (JACC) published in the global heart medical field has produced no small sensation, so the Canadian government pharmaceutical regulatory approval of the listing, and in Vancouver Sao Paulo Hospital took the lead in the introduction of the use. In addition, due to outstanding performance, "J-Valve involved in artificial biological heart valve" has been directly into the US Federal Food and Drug Administration (FDA) final approval process.


  Authoritative data show that heart failure has become the world's largest cause of death. And heart valve stenosis and can not be closed is one of the most important causes of heart failure, the world's existing heart valve patients 12 million, each year nearly 100 million people died, China is a high incidence of heart disease, with more than 2 million patients , Each year more than 200,000 patients need surgery, but the real treatment of patients but less than 1/3. China has 150,000 patients lost their chance of surgery every year.


  It is understood that "J-Valve involved in artificial biological heart valve system" has entered the sixth generation of products, and successfully completed the animal experiments and more than 100 cases of clinical treatment, the effect of extraordinary, become the State Food and Drug Administration "innovative medical Equipment special approval procedures (Trial) "innovative special approval project, this one-stop solution of the aortic valve will benefit the world tens of millions of heart valve patients. (Dong Wen) return to the bright home page

Contact us

这是描述信息

+86-512-63179788(WJ) | +86-512-63036288(SZ)

这是描述信息

Building4-1,Hi-Tech Park, Wujiang, Jiangsu Province, China

C21 Building, 218 Xinghu Street, Suzhou Industrial Park, China

这是描述信息

215200

FOLLOW US

这是描述信息

Mobile Website

这是描述信息

WeChat

Copyright ©  Suzhou Jiecheng Medical Technology Co., Ltd. 

这是描述信息